Topic
Urologic Oncology
131 Podcasts • 16 Cases • 8 Courses on BackTable
Hear how experienced clinicians in Urologic Oncology approach day-to-day decision-making on BackTable. Learn from podcasts, cases, and courses curated by physician content creators. Get the BackTable app to follow this Topic and hear more of the conversations that matter to your practice.
Episode # 323 • 11 Aug 2026
Managing Intermediate-Risk Bladder Cancer
Recurrent low-grade, intermediate-risk bladder cancer presents a unique treatment challenge: recurrence is common, progression is uncommon, and the burden of repeated procedures can add up quickly. On this episode of the BackTable Urology Podcast, Dr. Ruchika Talwar interviews Dr. Charles "Chas" Peyton about how to manage intermediate-risk bladder cancer patients while balancing disease control and quality of life. They discuss the cumulative impact of repeated TURBTs and explore the evolving role of office-based treatments and chemoablative therapies as alternatives to the traditional treatment cycle.
More on Urologic Oncology
Loading recent podcasts…
Urology # 323
Aug 10, 2026
with Dr. Charles Peyton, Dr. Ruchika Talwar
Recurrent low-grade, intermediate-risk bladder cancer presents a unique treatment challenge: recurrence is common,...
Urology # 317
Jul 16, 2026
with Dr. George R. Schade, Dr. Tiwa Akinsola
Can focal therapy truly “thread the needle” between active surveillance and radical prostate cancer treatment? In this...
1,300+ listens
Tumor Board # 71
Jul 6, 2026
with Dr. Rana McKay, Dr. Emmanuel Antonarakis, Dr. Alan Tan
With multiple clinical trials evaluating PARP inhibitor combinations, how do clinicians determine the best approach for...
Urology # 313
Jun 29, 2026
with Dr. Kirsten Greene, Dr. Ruchika Talwar
Is pelvic lymph node dissection still necessary in the era of PSMA PET imaging? In this episode of BackTable Urology,...
1,300+ listens
Urology # 320
Jul 30, 2026
with Dr. Sarah Psutka, Dr. Ruchika Talwar
Can a drug-eluting bladder device change the treatment algorithm for BCG-unresponsive non–muscle invasive bladder...
Urology # 316
Jul 13, 2026
with Dr. Adam Gadzinski, Dr. Ruchika Talwar
As bladder cancer treatment options expand, so do the challenges of delivering them in real-world practice. On this...
Urology # 314
Jul 6, 2026
with Dr. Rana McKay, Dr. Emmanuel Antonarakis, Dr. Alan Tan
With multiple clinical trials evaluating PARP inhibitor combinations, how do clinicians determine the best approach for...
Urology # 312
Jun 24, 2026
with Meredith Donahue NP, Mary Dunn NP, Dr. Vignesh Packiam
How can clinics minimize toxicity and maximize outcomes in intravesical bladder cancer treatment? In this episode of...
1,000+ listens
Tumor Board Case
Jun 23, 2025
with Dr. Nirmish Singla, Dr. Jeannie Hoffman-Censits and Dr. Bogdana Schmidt
Tumor Board Case
Jun 23, 2025
with Dr. Nirmish Singla, Dr. Jeannie Hoffman-Censits and Dr. Bogdana Schmidt
Tumor Board Case
Jun 16, 2025
with Dr. Juanita Crook, Dr. Andrea Apolo and Dr. Charles Peyton
Tumor Board Case
Jun 16, 2025
with Dr. Juanita Crook, Dr. Andrea Apolo and Dr. Charles Peyton
Tumor Board Case
Jun 23, 2025
with Dr. Nirmish Singla, Dr. Jeannie Hoffman-Censits and Dr. Bogdana Schmidt
Tumor Board Case
Jun 23, 2025
with Dr. Nirmish Singla, Dr. Jeannie Hoffman-Censits and Dr. Bogdana Schmidt
Tumor Board Case
Jun 16, 2025
with Dr. Juanita Crook, Dr. Andrea Apolo and Dr. Charles Peyton
Tumor Board Case
Jun 16, 2025
with Dr. Juanita Crook, Dr. Andrea Apolo and Dr. Charles Peyton
Urology Course
3 hours, 28 lessons
The Materials available on BackTable are provided for informational and educational purposes only and are not a substitute for the independent professional judgment of a qualified healthcare professional in diagnosing or treating patients. Any opinions, statements, or views expressed are those of the individual contributors and do not necessarily reflect those of the publisher, platform, or any affiliated organization.